Gm2 Gangliosidosis Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBBQ | C | Invesco Nasdaq Biotechnology ETF | 0.05 | |
IBB | D | iShares Nasdaq Biotechnology Index Fund | 0.04 | |
BIB | D | ProShares Ultra Nasdaq Biotechnology | 0.04 | |
VXF | C | Vanguard Extended Market ETF | 0.0 | |
ISCG | C | iShares Morningstar Small-Cap Growth ETF | 0.0 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Apr 20 | TSHA | Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher |
Related Industries:
Biotechnology
- Gm2 Gangliosidosis
Gm2 Gangliosidosis is a rare, inherited disorder caused by a deficiency of an enzyme called beta-hexosaminidase. This enzyme is responsible for breaking down certain fatty substances in the body called gangliosides. When the enzyme is deficient, these fatty substances accumulate in the brain and other organs, leading to a variety of neurological and physical symptoms. Symptoms of Gm2 Gangliosidosis can include seizures, developmental delays, muscle weakness, vision and hearing loss, and difficulty swallowing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles